Trevi Therapeutics Inc TRVI

NAS: TRVI | ISIN: US89532M1018   2/05/2024
3,010 USD (+5,24%)
(+5,24%)   2/05/2024

1 mei 2024 · Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 · Persbericht

9 april 2024 · Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference · Persbericht

4 april 2024 · Trevi Therapeutics to Participate in Upcoming April Events · Persbericht

2 april 2024 · Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team · Persbericht

20 maart 2024 · Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates · Persbericht

13 maart 2024 · Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 · Persbericht

28 februari 2024 · Trevi Therapeutics to Participate in Upcoming March Events · Persbericht

6 februari 2024 · Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference · Persbericht

4 januari 2024 · Trevi Therapeutics Provides Business Updates · Persbericht

5 december 2023 · Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF) · Persbericht

9 november 2023 · Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update · Persbericht

2 november 2023 · Trevi Therapeutics Announces the Initiation of its Phase 2a RIVER Clinical Trial of Haduvio™ for Refractory Chronic Cough · Persbericht

1 november 2023 · Trevi Therapeutics to Report Q3 2023 Financial Results and Provide a Corporate Update on November 9, 2023 · Persbericht

13 oktober 2023 · Trevi Therapeutics Announces Results from Phase 2b/3 PRISM Open-Label Extension Study of Haduvio™ in Prurigo Nodularis · Persbericht

6 september 2023 · Trevi Therapeutics to Participate in Upcoming September Events · Persbericht

10 augustus 2023 · Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update · Persbericht

3 augustus 2023 · Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023 · Persbericht

1 augustus 2023 · Trevi Therapeutics to Participate in Upcoming August Events · Persbericht

6 juli 2023 · Trevi Therapeutics to Participate in Upcoming July Investor Events · Persbericht

30 mei 2023 · Trevi Therapeutics to Participate in Upcoming June Conferences · Persbericht

Mijn selecties